Limitation of Acinetobacter Baumannii Treatment by Plasmid-Mediated Carbapenemase ARI-2

Lancet. 1998 Jan 17;351(9097):186-7. doi: 10.1016/S0140-6736(05)78210-6.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter / drug effects*
  • Acinetobacter / enzymology
  • Acinetobacter / genetics
  • Acinetobacter Infections / drug therapy*
  • Bacterial Proteins*
  • Humans
  • Imipenem / therapeutic use*
  • Metalloproteins / isolation & purification
  • Metalloproteins / pharmacology
  • Plasmids
  • Thienamycins / therapeutic use*
  • beta-Lactam Resistance*
  • beta-Lactamases / isolation & purification*
  • beta-Lactamases / pharmacology

Substances

  • Bacterial Proteins
  • Metalloproteins
  • Thienamycins
  • Imipenem
  • beta-Lactamases
  • carbapenemase